- Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by the loss of dopaminergic neurons, and there's a critical need for new therapies that can halt or reverse its progression, making gene therapy a promising option to explore.
- A systematic review evaluated the safety and effectiveness of gene therapy in PD by analyzing studies from databases like PubMed and Cochrane, with an emphasis on bias assessment and the neuroprotective potential of these treatments, which could repair neuronal damage and improve brain circuit function rather than just alleviating symptoms.
- The results suggest that gene therapy might offer advantages over traditional treatments, including reduced side effects, improved symptom relief, and more effective dopamine replacement; however, the need for more
Background: Fasting is known as a trigger for migraines. Muslims fast 1 month every luminal year. We aimed to study the impact of The Holy month of Ramadan on migraine headaches.